Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px
Document › Details

Abivax S.A.. (7/23/21). "Press Release: Abivax Announces the Pricing of Its Oversubscribed Capital Increase of EUR 60M and Convertible Bonds of EUR 25M, Totaling EUR 85M New Financing". Paris.

Organisations Organisation Abivax S.A. (Euronext Paris: ABVX)
  Group Abivax (Group)
  Organisation 2 Truffle Capital (FR)
Products Product obefazimod (ABX464)
  Product 2 ABX196 (Abivax)
Index terms Index term Abivax–SEVERAL: investment, 202107 capital increase €60m with 3% discount with 1.97m shares at €30.55/share
  Index term 2 Abivax–SEVERAL: credit, 202107– convertible bonds €25m at 6% interest/year
Persons Person Ehrlich, Hartmut J. (Abivax 201410 CEO before Baxter BioScience 200712 VP Global RnD)
  Person 2 Blondel, Didier (Abivax 201701– CFO before Sanofi Pasteur MSD + Sanofi)
     


   
Record changed: 2023-06-05

Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for Abivax (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x300px




» top